Browsing: posts

The better than projected financial performance was primarily driven by effective cost control, total electricity generation remaining above target throughout the year, and successful portfolio management through power trading, according to the financial report for 2025.

Regenerex Pharma, Inc. (RGPX) is a Nevada-based wound-care company focused on proprietary technologies for chronic and acute wounds, centered on its QBx™ platform and primary product, Accelerex™. Regenerex targets diabetic ulcers, pressure ulcers, burns and surgical wounds and highlights clinical data it states show high closure rates in non‑healing chronic wounds.

Pacific Booker Minerals Inc. (PBMLF) reports unaudited results for the three months ended April 30, 2026. The company recorded a net loss of $349,420 (loss per share $0.02), compared with a loss of $78,438 a year earlier, mainly due to higher professional and consulting fees tied to defending a hostile take-over bid.